An investigational drug (Favipiravir) study for patients who have been hospitalized with the coronavirus COVID-19.
7 Studies found
Seeking men and women who have been hospitalized with the coronavirus COVID-19 for a study of an experimental drug.
This program provides access to investigational convalescent plasma for hospitalized patients infected with SARS-CoV-2 who have severe or life-threatening COVID-19, or who are judged by a healthcare provider to be at high risk of progression to severe or life-threatening disease.
Seeking people, local to central Massachusetts, who are fully recovered from the new coronavirus to sign up to donate plasma to help current COVID-19 patients.
Seeking men and women who are in the hospital and diagnosed with COVID-19 for a study of an investigational drug to see if it acts as an anti-viral and anti-inflammatory treatment for COVID-19 infection.
Seeking people aged 12 and older who have been diagnosed with COVID-19 for an experimental treatment made from blood donated by people who have recovered from COVID-19.
Seeking hospitalized men and women who are receiving mechanical ventilation due to COVID-19 for a study to evaluate the efficacy and safety of an investigational drug.